HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Heart Rhythm, 8, 1308, 10.1016/j.hrthm.2011.05.020
Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631–2671.
Schwartz, 2009, Prevalence of the congenital long-QT syndrome, Circulation, 120, 1761, 10.1161/CIRCULATIONAHA.109.863209
Curran, 1995, A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome, Cell, 80, 795, 10.1016/0092-8674(95)90358-5
Wang, 1995, SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome, Cell, 80, 805, 10.1016/0092-8674(95)90359-3
Wang, 1996, Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias, Nat Genet, 12, 17, 10.1038/ng0196-17
Crotti, 2009, NOS1AP is a genetic modifier of the long-QT syndrome, Circulation, 120, 1657, 10.1161/CIRCULATIONAHA.109.879643
Johnson, 2008, Prevalence of early-onset atrial fibrillation in congenital long QT syndrome, Heart Rhythm, 5, 704, 10.1016/j.hrthm.2008.02.007
Zellerhoff, 2009, Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study, J Cardiovasc Electrophysiol, 20, 401, 10.1111/j.1540-8167.2008.01339.x
Schwartz, 2001, Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias, Circulation, 103, 89, 10.1161/01.CIR.103.1.89
Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147
Moss, 1995, ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome, Circulation, 92, 2929, 10.1161/01.CIR.92.10.2929
Schwartz, 1975, Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome, Am Heart J, 89, 45, 10.1016/0002-8703(75)90008-3
Malfatto, 1994, Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome, J Am Coll Cardiol, 23, 296, 10.1016/0735-1097(94)90410-3
Schwartz, 2011, QTc behavior during exercise and genetic testing for the long-QT syndrome, Circulation, 124, 2181, 10.1161/CIRCULATIONAHA.111.062182
Schwartz, 1993, Diagnostic criteria for the long QT syndrome. An update, Circulation, 88, 782, 10.1161/01.CIR.88.2.782
Goldenberg, 2011, Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals, J Am Coll Cardiol, 57, 51, 10.1016/j.jacc.2010.07.038
Viskin, 2010, The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome, J Am Coll Cardiol, 55, 1955, 10.1016/j.jacc.2009.12.015
Sy, 2011, Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands, Circulation, 124, 2187, 10.1161/CIRCULATIONAHA.111.028258
Horner, 2011, The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome, Heart Rhythm, 8, 1698, 10.1016/j.hrthm.2011.05.018
Vyas, 2006, Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response, Circulation, 113, 1385, 10.1161/CIRCULATIONAHA.105.600445
Shimizu, 2004, Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome, Heart Rhythm, 1, 276, 10.1016/j.hrthm.2004.04.021
Schwartz, 2006, The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome, Circulation, 113, 783, 10.1161/CIRCULATIONAHA.105.592899
Splawski, 2004, Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism, Cell, 119, 19, 10.1016/j.cell.2004.09.011
Barsheshet, 2012, Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome, Circulation, 125, 1988, 10.1161/CIRCULATIONAHA.111.048041
Migdalovich, 2011, Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome, Heart Rhythm, 8, 1537, 10.1016/j.hrthm.2011.03.049
Moss, 2002, Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel, Circulation, 105, 794, 10.1161/hc0702.105124
Shimizu, 2009, Genotype-phenotype aspects of type 2 long QT syndrome, J Am Coll Cardiol, 54, 2052, 10.1016/j.jacc.2009.08.028
Crotti, 2007, The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification, Circulation, 116, 2366, 10.1161/CIRCULATIONAHA.107.726950
Donger, 1997, KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome, Circulation, 96, 2778, 10.1161/01.CIR.96.9.2778
Goldenberg, 2008, Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome, Circulation, 117, 2184, 10.1161/CIRCULATIONAHA.107.701243
Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341
Schwartz, 2009, All LQT3 patients need an ICD: true or false?, Heart Rhythm, 6, 113, 10.1016/j.hrthm.2008.10.017
Spazzolini, 2009, Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy, J Am Coll Cardiol, 54, 832, 10.1016/j.jacc.2009.05.029
Locati, 1998, Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry, Circulation, 97, 2237, 10.1161/01.CIR.97.22.2237
Johnson, 2012, Competitive sports participation in athletes with congenital long QT syndrome, JAMA, 308, 764, 10.1001/jama.2012.9334
Chockalingam, 2012, Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol, J Am Coll Cardiol, 60, 2092, 10.1016/j.jacc.2012.07.046
Jons, 2010, Risk of fatal arrhythmic events in long QT syndrome patients after syncope, J Am Coll Cardiol, 55, 783, 10.1016/j.jacc.2009.11.042
Zareba, 2003, Implantable cardioverter defibrillator in high-risk long QT syndrome patients, J Cardiovasc Electrophysiol, 14, 337, 10.1046/j.1540-8167.2003.02545.x
Schwartz, 2010, Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry, Circulation, 122, 1272, 10.1161/CIRCULATIONAHA.110.950147
Horner, 2010, Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience, Heart Rhythm, 7, 1616, 10.1016/j.hrthm.2010.08.023
Vincent, 2009, High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”, Circulation, 119, 215, 10.1161/CIRCULATIONAHA.108.772533
Alexander, 2004, Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics, J Cardiovasc Electrophysiol, 15, 72, 10.1046/j.1540-8167.2004.03388.x
Kaufman, 2008, Risk of death in the long QT syndrome when a sibling has died, Heart Rhythm, 5, 831, 10.1016/j.hrthm.2008.02.029
Schwartz, 2004, Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome, Circulation, 109, 1826, 10.1161/01.CIR.0000125523.14403.1E
Moss, 1971, Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome, N Engl J Med, 285, 903, 10.1056/NEJM197110142851607
Ouriel, 1995, Long QT syndrome: an indication for cervicothoracic sympathectomy, Cardiovasc Surg, 3, 475, 10.1016/0967-2109(95)94444-2
Odero, 2010, Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy, Heart Rhythm, 7, 1161, 10.1016/j.hrthm.2010.03.046
Collura, 2009, Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery, Heart Rhythm, 6, 752, 10.1016/j.hrthm.2009.03.024
Schwartz, 1995, Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy, Circulation, 92, 3381, 10.1161/01.CIR.92.12.3381
Moss, 2005, Safety and efficacy of flecainide in subjects with long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial, Ann Noninvasive Electrocardiol, 10, 59, 10.1111/j.1542-474X.2005.00077.x
Moss, 2008, Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome, J Cardiovasc Electrophysiol, 19, 1289, 10.1111/j.1540-8167.2008.01246.x
Antzelevitch, 2005, Brugada syndrome: report of the second consensus conference, Heart Rhythm, 2, 429, 10.1016/j.hrthm.2005.01.005
Bezzina, 2006, Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction, Circulation, 113, 338, 10.1161/CIRCULATIONAHA.105.580811
Di Diego, 2002, Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males, Circulation, 106, 2004, 10.1161/01.CIR.0000032002.22105.7A
Shimizu, 2007, Sex hormone and gender difference: role of testosterone on male predominance in Brugada syndrome, J Cardiovasc Electrophysiol, 18, 415, 10.1111/j.1540-8167.2006.00743.x
van Hoorn, 2012, SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility, PLoS One, 7, e42037, 10.1371/journal.pone.0042037
Catalano, 2009, Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities, Eur Heart J, 30, 2241, 10.1093/eurheartj/ehp252
Sarkozy, 2011, The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern, Eur Heart J, 32, 2153, 10.1093/eurheartj/ehr129
Miyamoto, 2007, Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome, Am J Cardiol, 99, 53, 10.1016/j.amjcard.2006.07.062
Nagase, 2010, Electroanatomical correlation of repolarization abnormalities in Brugada syndrome: detection of type 1 electrocardiogram in the right ventricular outflow tract, J Am Coll Cardiol, 56, 2143, 10.1016/j.jacc.2010.06.050
Shimizu, 2005, Acquired forms of the Brugada syndrome, J Electrocardiol, 38, 22, 10.1016/j.jelectrocard.2005.06.005
Amin, 2009, Exercise-induced ECG changes in Brugada syndrome, Circ Arrhythm Electrophysiol, 2, 531, 10.1161/CIRCEP.109.862441
Makimoto, 2010, Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome, J Am Coll Cardiol, 56, 1576, 10.1016/j.jacc.2010.06.033
Ikeda, 2001, Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification, J Am Coll Cardiol, 37, 1628, 10.1016/S0735-1097(01)01197-4
Morita, 2008, Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome, Circulation, 118, 1697, 10.1161/CIRCULATIONAHA.108.770917
Priori, 2012, Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry, J Am Coll Cardiol, 59, 37, 10.1016/j.jacc.2011.08.064
Makimoto, 2012, Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram, Heart Rhythm, 9, 242, 10.1016/j.hrthm.2011.09.053
Brugada, 2002, Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3, Circulation, 105, 73, 10.1161/hc0102.101354
Brugada, 2003, Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest, Circulation, 108, 3092, 10.1161/01.CIR.0000104568.13957.4F
Brugada P., Brugada R., Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279–292; discussion 279–292.
Priori, 2002, Natural history of Brugada syndrome: insights for risk stratification and management, Circulation, 105, 1342, 10.1161/hc1102.105288
Eckardt, 2005, Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome, Circulation, 111, 257, 10.1161/01.CIR.0000153267.21278.8D
Brugada, 1992, Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report, J Am Coll Cardiol, 20, 1391, 10.1016/0735-1097(92)90253-J
Kamakura, 2009, Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1–V3, Circ Arrhythm Electrophysiol, 2, 495, 10.1161/CIRCEP.108.816892
Brugada, 1998, Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease, Circulation, 97, 457, 10.1161/01.CIR.97.5.457
Benito, 2008, Gender differences in clinical manifestations of Brugada syndrome, J Am Coll Cardiol, 52, 1567, 10.1016/j.jacc.2008.07.052
Gehi, 2006, Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis, J Cardiovasc Electrophysiol, 17, 577, 10.1111/j.1540-8167.2006.00455.x
Morita, 2002, Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome, J Am Coll Cardiol, 40, 1437, 10.1016/S0735-1097(02)02167-8
Kusano, 2008, Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds, J Am Coll Cardiol, 51, 1169, 10.1016/j.jacc.2007.10.060
Giustetto, 2009, Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study, Europace, 11, 507, 10.1093/europace/eup006
Probst, 2010, Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry, Circulation, 121, 635, 10.1161/CIRCULATIONAHA.109.887026
Viswanathan, 2003, A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation, J Clin Invest, 111, 341, 10.1172/JCI200316879
Meregalli, 2009, Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies, Heart Rhythm, 6, 341, 10.1016/j.hrthm.2008.11.009
Poelzing, 2006, SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene, Circulation, 114, 368, 10.1161/CIRCULATIONAHA.105.601294
Sacher, 2006, Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study, Circulation, 114, 2317, 10.1161/CIRCULATIONAHA.106.628537
Sarkozy, 2007, Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome, Eur Heart J, 28, 334, 10.1093/eurheartj/ehl450
Rosso, 2008, Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU), Isr Med Assoc J, 10, 435
Maury, 2005, Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options, Indian Pacing Electrophysiol J, 5, 25
Marquez, 2012, Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review, Heart Rhythm, 9, 1995, 10.1016/j.hrthm.2012.08.027
Schweizer, 2010, Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine, Clin Res Cardiol, 99, 467, 10.1007/s00392-010-0145-7
Kakishita, 2000, Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy, J Am Coll Cardiol, 36, 1646, 10.1016/S0735-1097(00)00932-3
Haissaguerre, 2003, Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes, Circulation, 108, 925, 10.1161/01.CIR.0000088781.99943.95
Darmon, 2004, Radiofrequency ablation of ventricular fibrillation and multiple right and left atrial tachycardia in a patient with Brugada syndrome, J Interv Card Electrophysiol, 11, 205, 10.1023/B:JICE.0000048571.19462.54
Nakagawa, 2008, Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome, Circ J, 72, 1025, 10.1253/circj.72.1025
Morita, 2009, Epicardial ablation eliminates ventricular arrhythmias in an experimental model of Brugada syndrome, Heart Rhythm, 6, 665, 10.1016/j.hrthm.2009.01.007
Nademanee, 2011, Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium, Circulation, 123, 1270, 10.1161/CIRCULATIONAHA.110.972612
Coumel, 1978, Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases, Br Heart J, 40, 28
Leenhardt, 1995, Catecholaminergic polymorphic ventricular tachycardia in children. A 7–year follow-up of 21 patients, Circulation, 91, 1512, 10.1161/01.CIR.91.5.1512
Priori, 2001, Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia, Circulation, 103, 196, 10.1161/01.CIR.103.2.196
Laitinen, 2001, Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia, Circulation, 103, 485, 10.1161/01.CIR.103.4.485
Lahat, 2001, A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel, Am J Hum Genet, 69, 1378, 10.1086/324565
Lahat, 2001, Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13–21, Circulation, 103, 2822, 10.1161/01.CIR.103.23.2822
Vega, 2009, Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia, Circ Arrhythm Electrophysiol, 2, 540, 10.1161/CIRCEP.109.872309
Bhuiyan, 2007, A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14–p22, J Cardiovasc Electrophysiol, 18, 1060, 10.1111/j.1540-8167.2007.00913.x
Mohler, 2004, A cardiac arrhythmia syndrome caused by loss of ankyrin-B function, Proc Natl Acad Sci U S A, 101, 9137, 10.1073/pnas.0402546101
Roux-Buisson, 2012, Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human, Hum Mol Genet, 21, 2759, 10.1093/hmg/dds104
Nyegaard, 2012, Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death, Am J Hum Genet, 91, 703, 10.1016/j.ajhg.2012.08.015
Sumitomo, 2003, Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death, Heart, 89, 66, 10.1136/heart.89.1.66
Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8
Hayashi, 2009, Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia, Circulation, 119, 2426, 10.1161/CIRCULATIONAHA.108.829267
Kazemian, 2011, A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by beta-blocker therapy, Can J Cardiol, 27, e7
Sumitomo, 2007, Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia, Circ J, 71, 1606, 10.1253/circj.71.1606
van der Werf, 2012, Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives, Circ Arrhythm Electrophysiol, 5, 748, 10.1161/CIRCEP.112.970517
di Barletta, 2006, Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia, Circulation, 114, 1012, 10.1161/CIRCULATIONAHA.106.623793
de la Fuente, 2008, A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations, Pacing Clin Electrophysiol, 31, 916, 10.1111/j.1540-8159.2008.01111.x
Postma, 2002, Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia, Circ Res, 91, e21, 10.1161/01.RES.0000038886.18992.6B
Roux-Buisson, 2011, Germline and somatic mosaicism for a mutation of the ryanodine receptor type 2 gene: implication for genetic counselling and patient caring, Europace, 13, 130, 10.1093/europace/euq331
van der Werf, 2012, Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments, Europace, 14, 175, 10.1093/europace/eur277
Venetucci, 2012, Inherited calcium channelopathies in the pathophysiology of arrhythmias, Nat Rev Cardiol, 9, 561, 10.1038/nrcardio.2012.93
Rosso, 2007, Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia, Heart Rhythm, 4, 1149, 10.1016/j.hrthm.2007.05.017
Swan, 2005, Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations, J Cardiovasc Electrophysiol, 16, 162, 10.1046/j.1540-8167.2005.40516.x
van der Werf, 2011, Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia, J Am Coll Cardiol, 57, 2244, 10.1016/j.jacc.2011.01.026
Watanabe, 2009, Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans, Nat Med, 15, 380, 10.1038/nm.1942
Wilde, 2008, Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia, N Engl J Med, 358, 2024, 10.1056/NEJMoa0708006
Atallah, 2008, Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias, Ann Thorac Surg, 86, 1620, 10.1016/j.athoracsur.2008.07.006
Gopinathannair, 2010, Delayed maximal response to left cardiac sympathectomy for catecholaminergic polymorphic ventricular tachycardia, Europace, 12, 1035, 10.1093/europace/euq058
Chen, 2011, The role of thoracic epidural blockade in predicting responsiveness to left sympathetic denervation in patients with catecholaminergic polymorphic ventricular tachycardia, J Cardiothorac Vasc Anesth, 25, 844, 10.1053/j.jvca.2010.08.001
Coleman, 2012, Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome, Circ Arrhythm Electrophysiol, 5, 782, 10.1161/CIRCEP.112.971754
Kaneshiro, 2012, Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation, Circ Arrhythm Electrophysiol, 5, e14, 10.1161/CIRCEP.111.966549
Gussak, 2000, Idiopathic short QT interval: a new clinical syndrome?, Cardiology, 94, 99, 10.1159/000047299
Gaita, 2003, Short QT Syndrome: a familial cause of sudden death, Circulation, 108, 965, 10.1161/01.CIR.0000085071.28695.C4
Brugada, 2004, Sudden death associated with short-QT syndrome linked to mutations in HERG, Circulation, 109, 30, 10.1161/01.CIR.0000109482.92774.3A
Bellocq, 2004, Mutation in the KCNQ1 gene leading to the short QT-interval syndrome, Circulation, 109, 2394, 10.1161/01.CIR.0000130409.72142.FE
Giustetto, 2011, Long-term follow-up of patients with short QT syndrome, J Am Coll Cardiol, 58, 587, 10.1016/j.jacc.2011.03.038
Priori, 2005, A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene, Circ Res, 96, 800, 10.1161/01.RES.0000162101.76263.8c
Antzelevitch, 2007, Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death, Circulation, 115, 442, 10.1161/CIRCULATIONAHA.106.668392
Gollob, 2011, The short QT syndrome: proposed diagnostic criteria, J Am Coll Cardiol, 57, 802, 10.1016/j.jacc.2010.09.048
Bjerregaard, 2011, Proposed diagnostic criteria for short QT syndrome are badly founded, J Am Coll Cardiol, 58, 549, 10.1016/j.jacc.2011.03.037
Veltmann, 2011, Arrhythmias: a “Schwartz score” for short QT syndrome, Nat Rev Cardiol, 8, 251, 10.1038/nrcardio.2011.51
Funada, 2008, Assessment of QT intervals and prevalence of short QT syndrome in Japan, Clin Cardiol, 31, 270, 10.1002/clc.20208
Mason, 2007, Chanter DO, et al. Electrocardiographic reference ranges derived from 79,743 ambulatory subjects, J Electrocardiol, 40, 228, 10.1016/j.jelectrocard.2006.09.003
Kobza, 2009, Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts, Heart Rhythm, 6, 652, 10.1016/j.hrthm.2009.01.009
Anttonen, 2007, Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population, Circulation, 116, 714, 10.1161/CIRCULATIONAHA.106.676551
Gaita, 2004, Short QT syndrome: pharmacological treatment, J Am Coll Cardiol, 43, 1494, 10.1016/j.jacc.2004.02.034
Gallagher, 2006, Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons, Am J Cardiol, 98, 933, 10.1016/j.amjcard.2006.04.035
Osborn, 1953, Experimental hypothermia; respiratory and blood pH changes in relation to cardiac function, Am J Physiol, 175, 389, 10.1152/ajplegacy.1953.175.3.389
Haissaguerre, 2008, Sudden cardiac arrest associated with early repolarization, N Engl J Med, 358, 2016, 10.1056/NEJMoa071968
Rosso, 2008, J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance, J Am Coll Cardiol, 52, 1231, 10.1016/j.jacc.2008.07.010
Abe, 2010, Circadian variation of late potentials in idiopathic ventricular fibrillation associated with J waves: insights into alternative pathophysiology and risk stratification, Heart Rhythm, 7, 675, 10.1016/j.hrthm.2010.01.023
Nam, 2010, Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome, Eur Heart J, 31, 330, 10.1093/eurheartj/ehp423
Derval, 2011, Prevalence and characteristics of early repolarization in the CASPER registry: cardiac arrest survivors with preserved ejection fraction registry, J Am Coll Cardiol, 58, 722, 10.1016/j.jacc.2011.04.022
Rosso, 2011, Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective, Heart Rhythm, 8, 923, 10.1016/j.hrthm.2011.01.037
Tikkanen, 2009, Long-term outcome associated with early repolarization on electrocardiography, N Engl J Med, 361, 2529, 10.1056/NEJMoa0907589
Sinner, 2010, Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA), PLoS Med, 7, e1000314, 10.1371/journal.pmed.1000314
Haruta, 2011, Incidence and prognostic value of early repolarization pattern in the 12–lead electrocardiogram, Circulation, 123, 2931, 10.1161/CIRCULATIONAHA.110.006460
Patel, 2010, Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease, Circ Arrhythm Electrophysiol, 3, 489, 10.1161/CIRCEP.109.921130
Noseworthy, 2011, The early repolarization pattern in the general population: clinical correlates and heritability, J Am Coll Cardiol, 57, 2284, 10.1016/j.jacc.2011.04.003
Junttila, 2011, Inferolateral early repolarization in athletes, J Interv Card Electrophysiol, 31, 33, 10.1007/s10840-010-9528-y
Sarkozy, 2009, Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome, Circ Arrhythm Electrophysiol, 2, 154, 10.1161/CIRCEP.108.795153
Watanabe, 2010, High prevalence of early repolarization in short QT syndrome, Heart Rhythm, 7, 647, 10.1016/j.hrthm.2010.01.012
Nunn, 2011, Prevalence of J-point elevation in sudden arrhythmic death syndrome families, J Am Coll Cardiol, 58, 286, 10.1016/j.jacc.2011.03.028
Reinhard, 2011, Heritability of early repolarization: a population-based study, Circ Cardiovasc Genet, 4, 134, 10.1161/CIRCGENETICS.110.958298
Haissaguerre, 2009, Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel, J Cardiovasc Electrophysiol, 20, 93, 10.1111/j.1540-8167.2008.01326.x
Medeiros-Domingo, 2010, Gain-of-function mutation S422L in the KCNJ8–encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes, Heart Rhythm, 7, 1466, 10.1016/j.hrthm.2010.06.016
Burashnikov, 2010, Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death, Heart Rhythm, 7, 1872, 10.1016/j.hrthm.2010.08.026
Watanabe, 2011, Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization, Circ Arrhythm Electrophysiol, 4, 874, 10.1161/CIRCEP.111.963983
Sinner, 2012, A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern, Heart Rhythm, 9, 1627, 10.1016/j.hrthm.2012.06.008
Uberoi, 2011, Early repolarization in an ambulatory clinical population, Circulation, 124, 2208, 10.1161/CIRCULATIONAHA.111.047191
Tikkanen, 2011, Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome, Circulation, 123, 2666, 10.1161/CIRCULATIONAHA.110.014068
Rosso, 2012, Distinguishing “benign” from “malignant early repolarization”: the value of the ST-segment morphology, Heart Rhythm, 9, 225, 10.1016/j.hrthm.2011.09.012
Wu, 2013, Early repolarization pattern and risk for arrhythmia death: a meta-analysis, J Am Coll Cardiol, 61, 645, 10.1016/j.jacc.2012.11.023
Nam, 2008, Augmentation of J waves and electrical storms in patients with early repolarization, N Engl J Med, 358, 2078, 10.1056/NEJMc0708182
Haissaguerre, 2009, Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy, J Am Coll Cardiol, 53, 612, 10.1016/j.jacc.2008.10.044
Smits, 2005, Mechanisms of inherited cardiac conduction disease, Europace, 7, 122, 10.1016/j.eupc.2004.11.004
Schott, 2008, Progressive cardiac conduction disease, 564
Stallmeyer, 2012, Mutational spectrum in the Ca(2+)activated cation channel gene TRPM4 in patients with cardiac conductance disturbances, Hum Mutat, 33, 109, 10.1002/humu.21599
Kruse, 2009, Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I, J Clin Invest, 119, 2737, 10.1172/JCI38292
Wolf, 2008, Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease, J Mol Cell Cardiol, 44, 293, 10.1016/j.yjmcc.2007.11.008
Wolf, 2006, Inherited conduction system abnormalities: one group of diseases, many genes, J Cardiovasc Electrophysiol, 17, 446, 10.1111/j.1540-8167.2006.00427.x
van Berlo, 2005, Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?, J Mol Med (Berl), 83, 79, 10.1007/s00109-004-0589-1
Taylor, 2003, Natural history of dilated cardiomyopathy due to lamin A/C gene mutations, J Am Coll Cardiol, 41, 771, 10.1016/S0735-1097(02)02954-6
Parks, 2008, Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy, Am Heart J, 156, 161, 10.1016/j.ahj.2008.01.026
Epstein, 2008, ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities, Heart Rhythm, 5, e1, 10.1016/j.hrthm.2008.04.014
van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078
Priori, 1992, Unexplained cardiac arrest. The need for a prospective registry, Eur Heart J, 13, 1445, 10.1093/oxfordjournals.eurheartj.a060083
Krahn, 2009, Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER), Circulation, 120, 278, 10.1161/CIRCULATIONAHA.109.853143
Mazzanti, 2012, Molecular autopsy for sudden unexplained death? Time to discuss pros and cons, J Cardiovasc Electrophysiol, 23, 1099, 10.1111/j.1540-8167.2012.02430.x
Priori, 2009, Arrhythmias: unexplained sudden cardiac death: back to clinical evaluation, Nat Rev Cardiol, 6, 678, 10.1038/nrcardio.2009.174
Bai, 2009, Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing, Circ Arrhythm Electrophysiol, 2, 6, 10.1161/CIRCEP.108.782888
Crijns, 1995, Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias, Br Heart J, 74, 408, 10.1136/hrt.74.4.408
Belhassen, 1998, Management of idiopathic ventricular fibrillation: implantable defibrillators? antiarrhythmic drugs?, Ann Noninvasive Electrocardiol, 3, 125, 10.1111/j.1542-474X.1998.tb00409.x
Remme, 2001, Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation, Eur Heart J, 22, 400, 10.1053/euhj.2000.2366
Knecht, 2009, Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study, J Am Coll Cardiol, 54, 522, 10.1016/j.jacc.2009.03.065
Myerburg, 1992, Sudden cardiac death. Structure, function, and time-dependence of risk, Circulation, 85, I2
Behr, 2003, Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome, Lancet, 362, 1457, 10.1016/S0140-6736(03)14692-2
Behr, 2007, Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death, Heart, 93, 601, 10.1136/hrt.2006.099598
Bowker, 2003, Sudden, unexpected cardiac or unexplained death in England: a national survey, QJM, 96, 269, 10.1093/qjmed/hcg038
Vatta, 2002, Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome, Hum Mol Genet, 11, 337, 10.1093/hmg/11.3.337
Krous, 2004, Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach, Pediatrics, 114, 234, 10.1542/peds.114.1.234
Winkel, 2011, Nationwide study of sudden cardiac death in persons aged 1–35 years, Eur Heart J, 32, 983, 10.1093/eurheartj/ehq428
Corrado, 2001, Sudden cardiac death in young people with apparently normal heart, Cardiovasc Res, 50, 399, 10.1016/S0008-6363(01)00254-1
van der Werf, 2010, Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands, Heart Rhythm, 7, 1383, 10.1016/j.hrthm.2010.05.036
De Noronha S.V., Behr E., Papadakis M., et al. The importance of expert cardiac pathology for the investigation of sudden cardiac death; results from a British fast track cardiac pathology service 2011. August poster session presented at ESC Congress 2011, August 27–31, 2011, Paris, France.
Margey, 2011, Sudden cardiac death in 14– to 35–year olds in Ireland from 2005 to 2007: a retrospective registry, Europace, 13, 1411, 10.1093/europace/eur161
Eckart, 2004, Sudden death in young adults: a 25–year review of autopsies in military recruits, Ann Intern Med, 141, 829, 10.7326/0003-4819-141-11-200412070-00005
de Noronha, 2009, Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study, Heart, 95, 1409, 10.1136/hrt.2009.168369
McGarvey, 2012, Sudden unexplained death in childhood (1–4 years) in Ireland: an epidemiological profile and comparison with SIDS, Arch Dis Child, 97, 692, 10.1136/archdischild-2011-301393
Chugh, 2009, Population-based analysis of sudden death in children: The Oregon Sudden Unexpected Death Study, Heart Rhythm, 6, 1618, 10.1016/j.hrthm.2009.07.046
Trachtenberg, 2012, Risk factor changes for sudden infant death syndrome after initiation of back-to-sleep campaign, Pediatrics, 129, 630, 10.1542/peds.2011-1419
Basso, 2008, Guidelines for autopsy investigation of sudden cardiac death, Virchows Arch, 452, 11, 10.1007/s00428-007-0505-5
Papadakis, 2013, Sudden cardiac death with autopsy findings of uncertain signficance: potential for erroneous interpretation, Circ Arrhythm Electrophysiol, 10.1161/CIRCEP.113.000111
Raju, 2011, Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome, J Am Coll Cardiol, 57, 2340, 10.1016/j.jacc.2010.11.067
Tester, 2006, The role of molecular autopsy in unexplained sudden cardiac death, Curr Opin Cardiol, 21, 166, 10.1097/01.hco.0000221576.33501.83
Tan, 2005, Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives, Circulation, 112, 207, 10.1161/CIRCULATIONAHA.104.522581
Behr, 2008, Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families, Eur Heart J, 29, 1670, 10.1093/eurheartj/ehn219
Priori, 2006, Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies, Circulation, 113, 1130, 10.1161/CIRCULATIONAHA.105.563205
Hofman, 2010, Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?, J Am Coll Cardiol, 55, 2570, 10.1016/j.jacc.2009.12.063
Nunn, 2011, Genetics and cardiovascular disease: causes and prevention of unexpected sudden adult death: the role of the SADS clinic, Heart, 97, 1122, 10.1136/hrt.2010.218511
Ingles, 2011, The emerging role of the cardiac genetic counselor, Heart Rhythm, 8, 1958, 10.1016/j.hrthm.2011.07.017
van Langen, 2003, Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era?, Eur Heart J, 24, 560, 10.1016/S0195-668X(02)00522-5
Hendriks, 2008, Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome, Heart Rhythm, 5, 719, 10.1016/j.hrthm.2008.01.032
Hendriks, 2005, Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome, Am J Med Genet A, 138A, 107, 10.1002/ajmg.a.30861
Hendriks, 2005, High distress in parents whose children undergo predictive testing for long QT syndrome, Community Genet, 8, 103, 10.1159/000084778
Christiaans, 2009, Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective, Am J Med Genet A, 149A, 1444, 10.1002/ajmg.a.32915
Christiaans, 2009, Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study, Am J Med Genet A, 149A, 602, 10.1002/ajmg.a.32710
Hoedemaekers, 2007, Jaspers JP, Van Tintelen JP. The influence of coping styles and perceived control on emotional distress in persons at risk for a hereditary heart disease, Am J Med Genet A, 143A, 1997, 10.1002/ajmg.a.31871
Hamang, 2011, General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety: a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death, Health Qual Life Outcomes, 9, 100, 10.1186/1477-7525-9-100
Christiaans, 2010, Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers, Eur J Hum Genet, 18, 251, 10.1038/ejhg.2009.145
van Langen, 2004, Family and population strategies for screening and counselling of inherited cardiac arrhythmias, Ann Med, 36, 116, 10.1080/17431380410032526
Christiaans, 2008, Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy, Eur J Hum Genet, 16, 1201, 10.1038/ejhg.2008.92
Cohen, 2012, Walsh , et al. Challenges of genetic testing in adolescents with cardiac arrhythmia syndromes, J Med Ethics, 38, 163, 10.1136/medethics-2011-100087
Caldwell, 2012, The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated, Heart, 98, 631, 10.1136/heartjnl-2011-300924